A comparison of intensive insulin therapy and dipeptidyl peptidase-4 inhibitor plus metformin combination in newly diagnosed type 2 diabetes mellitus

被引：0
|
作者：
Diri, Halit [1 ,2 ]
Bolayir, Basak [1 ]
Soylu, Hikmet [1 ]
Cetin, Sedat [1 ]
Simsek, Mehmet [1 ]
机构：
[1] Diyarbakir Gazi Yasargil Training & Res Hosp, Dept Endocrinol, Diyarbakir, Turkiye
[2] Diyarbakir Gazi Yasargil Training & Res Hosp, Dept Endocrinol, TR-21070 Diyarbakir, Turkiye
来源：
MINERVA ENDOCRINOLOGY | 2024年 / 49卷 / 02期
关键词：
D O I：
10.23736/S2724-6507.23.03928-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：228 / 230
页数：3
相关论文
共 50 条
  • [1] Optimizing the treatment of newly diagnosed type 2 diabetes mellitus with combination of dipeptidyl peptidase-4 inhibitors and metformin: An expert opinion
    Das, Ashok K.
    Gandhi, Pramod
    Saboo, Banshi
    Reddy, Sanjay
    Chawla, Rajeev
    Zargar, Abdul Hamid
    Kovil, Rajiv
    Chawla, Manoj
    Sharma, S. K.
    Gupta, Sunil
    Makkar, B. M.
    Mittal, Vinod
    Goswami, Soumik
    Arvind, S. R.
    Jaggi, Shalini
    Bajaj, Sarita
    Das, Sambit
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2021, 10 (12) : 4398 - 4409
  • [2] Combination therapy of metformin plus dipeptidyl peptidase-4 inhibitor versus metformin plus sulfonylurea and their association with a decreased risk of cardiovascular disease in type 2 diabetes mellitus patients
    Wang, Fei
    He, Yuan
    Zhang, Rong
    Zeng, Qiang
    Zhao, Xiaolan
    MEDICINE, 2017, 96 (36)
  • [3] Use of the dipeptidyl peptidase-4 inhibitor linagliptin in combination therapy for type 2 diabetes
    Lajara, Rosemarie
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (18) : 2663 - 2671
  • [4] Combination therapy of dipeptidyl peptidase-4 inhibitors and metformin in type 2 diabetes: rationale and evidence
    Liu, Y.
    Hong, T.
    DIABETES OBESITY & METABOLISM, 2014, 16 (02): : 111 - 117
  • [5] Circulating dipeptidyl peptidase-4 activity is decreased by short-term intensive insulin therapy in patients with newly diagnosed type 2 diabetes
    Liehua, L.
    Ke, W.
    Li, H.
    Liu, J.
    He, X.
    Chen, J.
    Li, Y.
    DIABETOLOGIA, 2018, 61 : S447 - S448
  • [6] Saxagliptin: A dipeptidyl peptidase-4 inhibitor in the treatment of type 2 diabetes mellitus
    Dave, Darshan J.
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2011, 2 (04) : 230 - 235
  • [7] Linagliptin: The Newest Dipeptidyl Peptidase-4 Inhibitor for Type 2 Diabetes Mellitus
    Aletti, Rachael
    Cheng-Lai, Angela
    CARDIOLOGY IN REVIEW, 2012, 20 (01) : 45 - 51
  • [8] Saxagliptin: A dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes mellitus
    Neumiller, Joshua J.
    Campbell, R. Keith
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (18) : 1515 - 1525
  • [9] Alogliptin: A New Dipeptidyl Peptidase-4 Inhibitor for Type 2 Diabetes Mellitus
    Jarvis, Courtney I.
    Cabrera, Adriana
    Charron, Derek
    ANNALS OF PHARMACOTHERAPY, 2013, 47 (11) : 1532 - 1539
  • [10] Dutogliptin, a dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes mellitus
    Johnson, Kathryn M. S.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2010, 11 (04) : 455 - 463
12345